T&L Co., Ltd. (KOSDAQ:340570)
South Korea · Delayed Price · Currency is KRW 43,550
-350 (-0.80%)
At close: Jan 19, 2026
T&L Co., Ltd. Market Cap
T&L Co., Ltd. has a market cap or net worth of 351.54 billion as of January 16, 2026. Its market cap has decreased by -31.74% in one year.
Market Cap
351.54B
Enterprise Value
261.99B
Revenue
177.27B
Ranking
n/a
PE Ratio
8.03
Stock Price
43,550.00
Market Cap Chart
Since November 20, 2020, T&L Co., Ltd.'s market cap has increased from 219.46B to 351.54B, an increase of 60.19%. That is a compound annual growth rate of 9.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 354.36B | -10.50% |
| Dec 30, 2025 | 395.93B | -26.68% |
| Dec 30, 2024 | 540.02B | 67.25% |
| Dec 28, 2023 | 322.88B | 10.50% |
| Dec 29, 2022 | 292.21B | -23.99% |
| Dec 30, 2021 | 384.45B | 121.03% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 90.13T |
| Celltrion | 45.73T |
| ALTEOGEN | 27.70T |
| ABL Bio | 10.89T |
| SK Biopharmaceuticals | 9.43T |
| Yuhan | 8.05T |
| HLB Co., Ltd. | 6.97T |
| Sam Chun Dang Pharm. | 6.49T |